Search research articles
Contact Us
Filters
Showing results (1-10 of 106) with videos related to
Page
of 11
Sort By:
The Lancet. Oncology
|
September 9, 2017
Why is survival after pembrolizumab affected by previous radiotherapy? - Authors' reply
Percy Lee, Narek Shaverdian
JAMA Oncology
|
October 5, 2023
When Headlines Harm Patients With Cancer
Narek Shaverdian, Reshma Jagsi
Oncotarget
|
December 8, 2017
Radiotherapy: the key to immunotherapy ignition?
Elaine Luterstein, Narek Shaverdian, Percy Lee
Patient Related Outcome Measures
|
July 30, 2019
Truthfulness in patient-reported outcomes: factors affecting patients' responses and impact on data quality
Eric M Chang, Erin F Gillespie, Narek Shaverdian
International Journal of Radiation Oncology, Biology, Physics
|
June 8, 2017
In Reply to Scott
Narek Shaverdian, Michael L Steinberg, Christopher R King
JAMA Network Open
|
April 8, 2026
Can Facial Analysis Augment Clinical Decision-Making in NSCLC?
David Gibbes Miller, Tafadzwa L Chaunzwa, Narek Shaverdian
Lung Cancer (Amsterdam, Netherlands)
|
September 12, 2015
The patient's perspective on stereotactic body radiation therapy (SBRT) vs. surgery for treatment of early stage non-small cell lung cancer (NSCLC)
Narek Shaverdian, Pin-Chieh Wang, Michael Steinberg, et al.
Cureus
|
March 25, 2025
Treatment of Primary Pulmonary Synovial Sarcoma in a Low-Resource Country: A Case Report
Araksi Gasparyan, Tatul Saghatelyan, Sergey Abrahamyan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 6, 2024
A Promising Step Forward With Giant Leaps Ahead
Narek Shaverdian, Bob T Li, James Isbell, et al.
Clinical Lung Cancer
|
June 30, 2018
Comparing Outcomes of Patients With Early-Stage Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status
Govind Raghavan, Narek Shaverdian, Shawna Chan, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 106) with videos related to
Sort By:
Page
of 11
The Lancet. Oncology
|
September 9, 2017
Why is survival after pembrolizumab affected by previous radiotherapy? - Authors' reply
Percy Lee, Narek Shaverdian
JAMA Oncology
|
October 5, 2023
When Headlines Harm Patients With Cancer
Narek Shaverdian, Reshma Jagsi
Oncotarget
|
December 8, 2017
Radiotherapy: the key to immunotherapy ignition?
Elaine Luterstein, Narek Shaverdian, Percy Lee
Patient Related Outcome Measures
|
July 30, 2019
Truthfulness in patient-reported outcomes: factors affecting patients' responses and impact on data quality
Eric M Chang, Erin F Gillespie, Narek Shaverdian
International Journal of Radiation Oncology, Biology, Physics
|
June 8, 2017
In Reply to Scott
Narek Shaverdian, Michael L Steinberg, Christopher R King
JAMA Network Open
|
April 8, 2026
Can Facial Analysis Augment Clinical Decision-Making in NSCLC?
David Gibbes Miller, Tafadzwa L Chaunzwa, Narek Shaverdian
Lung Cancer (Amsterdam, Netherlands)
|
September 12, 2015
The patient's perspective on stereotactic body radiation therapy (SBRT) vs. surgery for treatment of early stage non-small cell lung cancer (NSCLC)
Narek Shaverdian, Pin-Chieh Wang, Michael Steinberg, et al.
Cureus
|
March 25, 2025
Treatment of Primary Pulmonary Synovial Sarcoma in a Low-Resource Country: A Case Report
Araksi Gasparyan, Tatul Saghatelyan, Sergey Abrahamyan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 6, 2024
A Promising Step Forward With Giant Leaps Ahead
Narek Shaverdian, Bob T Li, James Isbell, et al.
Clinical Lung Cancer
|
June 30, 2018
Comparing Outcomes of Patients With Early-Stage Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status
Govind Raghavan, Narek Shaverdian, Shawna Chan, et al.
Page
of 11